Hot Keywords

HANGZHOU HOLYPHARM BIOTECH CO.,LTD

Country:China (Mainland)

Year Established: 2009Business type: Other

Integral:

1. Belviq
Belviq
is supplied as a tablet designed for oral administration. The recommended dose is one 10mg tablet twice daily. Use of Belviq should be discontinued if 5% weight loss is not achieved by week 12 of treatment.

2. Clinical research:
Someone had done some research about the using result of lorcaserin. And the FDA approval of Belviq was based on the results of three randomized, double-blind, placebo-controlled trials with durations ranging from 52 to 104 weeks. The primary endpoint for each study was weight loss at one year as assessed by percent of subjects achieving greater than or equal to 5% weight loss, percent of subjects achieving greater than or equal to 10% weight loss, and mean weight change.

3. Lorcaserin side effects:
Although lorcaserin has great effects on lossing weight, but the most common side effect is headache. Other reported side effects respectively are as follows: upper respiratory tract infection, nasopharyngitis, sinusitis and nausea. Even adverse events of depression, anxiety and suicidal ideation were reported.

There is someone had done some researchs about non-diabetic use or diabetic use of Belviq, the research result was reported as follows:
Adverse reactions associated with the non-diabetic use of Belviq may include:
•headache
•dizziness
•fatigue
•nausea
•dry mouth
•constipation

Adverse reactions associated with the diabetic use of Belviq may include:
•hypoglycemia
•headache
•back pain
•cough
•fatigue

Other products from this supplier

indacaterol side effects

Even though Indacaterol is of great significance to the people with chronic obstructive pulmonary disease (COPD), it also causes many side effects.

Xeloda

Xeloda basic information and its prouct and usage

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View